ANEB vs FITB · $15.3M cap vs P/E 17, rev $3.37B
Anebulo Pharmaceuticals Inc (ANEB) versus Fifth Third Bancorp (FITB) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
ANEB does not have a complete income-statement cache yet.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
ANEB currently screens at market cap $15.3M. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Not investment advice. Open the ANEB and FITB stock pages for the full models.
Not investment advice.